These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15286206)

  • 1. Long-term administration of Delta9-tetrahydrocannabinol desensitizes CB1-, adenosine A1-, and GABAB-mediated inhibition of adenylyl cyclase in mouse cerebellum.
    Selley DE; Cassidy MP; Martin BR; Sim-Selley LJ
    Mol Pharmacol; 2004 Nov; 66(5):1275-84. PubMed ID: 15286206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory.
    Sousa VC; Assaife-Lopes N; Ribeiro JA; Pratt JA; Brett RR; Sebastião AM
    Neuropsychopharmacology; 2011 Jan; 36(2):472-87. PubMed ID: 20927050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional interaction and cross-tolerance between ethanol and Δ9-THC: possible modulation by mouse cerebellar adenosinergic A1/GABAergic-A receptors.
    Dar MS
    Behav Brain Res; 2014 Aug; 270():287-94. PubMed ID: 24875771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase.
    Bayewitch M; Rhee MH; Avidor-Reiss T; Breuer A; Mechoulam R; Vogel Z
    J Biol Chem; 1996 Apr; 271(17):9902-5. PubMed ID: 8626625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats.
    Garcia-Gil L; de Miguel R; Romero J; Perez A; Ramos JA; Fernández-Ruiz JJ
    Neurotoxicol Teratol; 1999; 21(3):277-83. PubMed ID: 10386831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner.
    Nguyen PT; Schmid CL; Raehal KM; Selley DE; Bohn LM; Sim-Selley LJ
    Biol Psychiatry; 2012 Apr; 71(8):714-24. PubMed ID: 22264443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors.
    Savinainen JR; Saario SM; Niemi R; Järvinen T; Laitinen JT
    Br J Pharmacol; 2003 Dec; 140(8):1451-9. PubMed ID: 14623770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα
    Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP
    Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cannabinoid receptors in cultures of rat cerebellar granule cells.
    Pacheco MA; Ward SJ; Childers SR
    Brain Res; 1993 Feb; 603(1):102-10. PubMed ID: 8384043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of cannabinoid CB1, adenosine A1, muscarinic acetylcholine, and GABA(B) receptor-dependent G protein activity in transducin-deactivated membranes and autoradiography sections of rat retina.
    Savinainen JR; Laitinen JT
    Cell Mol Neurobiol; 2004 Apr; 24(2):243-56. PubMed ID: 15176438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine 1A receptor-dependent mechanisms.
    Mato S; Vidal R; Castro E; Díaz A; Pazos A; Valdizán EM
    Mol Pharmacol; 2010 Mar; 77(3):424-34. PubMed ID: 19995940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization of adenosine A1 receptor-mediated inhibition of adenylyl cyclase in cerebellar granule cells.
    Vendite D; Sanz JM; López-Alañon DM; Vacas J; Andrés A; Ros M
    Neurochem Res; 1998 Feb; 23(2):211-8. PubMed ID: 9475516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain.
    Sim LJ; Hampson RE; Deadwyler SA; Childers SR
    J Neurosci; 1996 Dec; 16(24):8057-66. PubMed ID: 8987831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol.
    McKinney DL; Cassidy MP; Collier LM; Martin BR; Wiley JL; Selley DE; Sim-Selley LJ
    J Pharmacol Exp Ther; 2008 Feb; 324(2):664-73. PubMed ID: 17967938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells.
    Chern Y; Lai HL; Fong JC; Liang Y
    Mol Pharmacol; 1993 Nov; 44(5):950-8. PubMed ID: 8246918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebellar CB(1) receptor mediation of Delta(9)-THC-induced motor incoordination and its potentiation by ethanol and modulation by the cerebellar adenosinergic A(1) receptor in the mouse.
    Dar MS
    Brain Res; 2000 May; 864(2):186-94. PubMed ID: 10802025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function.
    Eldeeb K; Leone-Kabler S; Howlett AC
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):311-22. PubMed ID: 27089415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased GABAA and GABAB receptor functional activity in cannabinoid CB1 receptor knockout mice.
    Urigüen L; García-Gutiérrez MS; Manzanares J
    J Psychopharmacol; 2011 Jan; 25(1):105-10. PubMed ID: 20142297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid agonist signal transduction in rat brain: comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenylyl cyclase inhibition.
    Breivogel CS; Childers SR
    J Pharmacol Exp Ther; 2000 Oct; 295(1):328-36. PubMed ID: 10991998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse cerebellar GABAB participation in the expression of acute ethanol-induced ataxia and in its modulation by the cerebellar adenosinergic A1 system.
    Dar MS
    Brain Res Bull; 1996; 41(1):53-9. PubMed ID: 8883916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.